Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion type Assertion NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_head.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion description "[Nine previously untreated patients with Philadelphia chromosome-positive chronic myelocytic leukemia (CML) were treated with recombinant interferon alpha 2a (rIFN-alpha 2a) and hydroxyurea.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion evidence source_evidence_literature NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion SIO_000772 2736308 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion wasDerivedFrom befree-20150227 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.
- NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_assertion wasGeneratedBy ECO_0000203 NP477288.RA9b5dhRgf3cjk8oG3Lx3tmZHwi3MPNzLQgyP4HJ0mAHM130_provenance.